AGTC Applied Genetic Technologies Corp

Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/27/2014
Outstanding shares:  42,859,675
Average volume:  464,778
Market cap:   $117,006,913
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03820J100
ISIN:        US03820J1007
Valuation   (See tab for details)
PE ratio:   -9.39
PB ratio:   1.33
PS ratio:   234.01
Return on equity:   -67.39%
Net income %:   -11,565.80%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy